Compare
IDT Corp vs Crexendo, Inc. vs Anterix Inc.
| Latest fiscal year | IDT Corp IDT | Crexendo, Inc. CXDO | Anterix Inc. ATEXRevenue covers only part of its income (partial revenue) |
|---|---|---|---|
| Year ended | 2026-07-31 | 2025-12-31 | 2026-03-31 |
| Revenue | $1.30B | $68.17M | n/a |
| Revenue growth (YoY) | +5.4% | +12.0% | n/a |
| Gross margin | 38.3% | n/a | n/a |
| Operating margin | 9.3% | 6.9% | n/a |
| Net margin | 6.7% | 7.4% | n/a |
| Net income | $86.63M | $5.07M | $90.64M |
| EPS (Diluted) | $3.46 | $0.16 | $4.83 |
| Operating cash flow | $91.07M | $9.30M | $5.51M |
| Free cash flow | $67.96M | $9.28M | $5.48M |
| Cash & equivalents | $220.69M | n/a | $98.53M |
| Total assets | $764.26M | $77.69M | $465.21M |
| Total liabilities | $356.31M | $13.87M | $202.89M |
| Shareholders' equity | $396.11M | $63.82M | $262.32M |
| Return on year-end equity | 21.9% | 7.9% | 34.6% |
| Shares outstanding | n/a | 31.00M | 18.91M |
Revenue, most recent five fiscal years
| Fiscal year | IDT Corp | Crexendo, Inc. | Anterix Inc. |
|---|---|---|---|
| Latest | $1.30B Ended 2026-07-31 | $68.17M Ended 2025-12-31 | n/a |
| 1 year earlier | $1.23B Ended 2025-07-31 | $60.84M Ended 2024-12-31 | n/a |
| 2 years earlier | $1.21B Ended 2024-07-31 | $53.20M Ended 2023-12-31 | n/a |
| 3 years earlier | $1.24B Ended 2023-07-31 | $37.55M Ended 2022-12-31 | n/a |
| 4 years earlier | $1.36B Ended 2022-07-31 | $28.09M Ended 2021-12-31 | n/a |